Cerebrolysin
Research profile · How we handle evidence
Cerebrolysin is a prescription injectable product made from a standardized mixture of peptides and amino acids. In some countries it’s used in clinical care for neurorecovery after ischemic stroke and for certain dementia-related indications. Because it’s administered by injection and regulated as a medicine, it should only be used with clinician oversight—not as a supplement or self-experiment.
Evidence Score
High confidence
Category
Therapeutic area
Standard Dose
Daily for 10-20 days
Half-life
Plasma elimination
Route
Intravenous or Intramuscular
Safety Tier
Limited data
Overview
Cerebrolysin is an injectable medicine used in some clinical settings to support recovery after stroke and, in selected cases, cognitive symptoms related to dementia. In practice it’s given as a short course of injections under a prescriber’s guidance.
Mechanism of Action
Cerebrolysin is an injectable medicine used in some clinical settings to support recovery after stroke and, in selected cases, cognitive symptoms related to dementia. In practice it’s given as a short course of injections under a prescriber’s guidance.
pH & Mixing
Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.
A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.
Benefits
- Neuroprotective (neurorecovery support)
- May support functional recovery after ischemic stroke
- May improve some cognitive outcomes in selected patients
Side Effects
- Headache
- Dizziness
- Nausea or other gastrointestinal upset may occur
- Injection-site reactions
- Rare hypersensitivity or allergic reactions
Contraindications
- Pregnant or breastfeeding women
- Individuals under 18 years old
- Those with known hypersensitivity to any component of the preparation
Structure & Sequence
Verified structure
Cerebrolysin
Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.
- Amino Acid Sequence
- Not a single peptide - Cerebrolysin is a standardized enzymatic hydrolysate of porcine brain proteins: roughly 15-25% low-molecular-weight peptide fragments (under 10 kDa, including fragments resembling NGF, BDNF, CNTF, and enkephalins) plus 75-85% free amino acids (Asp, Glu, Ser, His, Gly, Thr, Ala, Arg, Val, Met, Trp, Ile, Phe, Leu, Lys, Pro). No single defined sequence exists for the product as a whole.
- CAS Number
- N/A
- Reconstituted pH
- 6.9-7.5
Stack & Route Context
Stacks with
- Noopept
- Modafinil
Administration
Intravenous or Intramuscular
Research Status
Used as a prescription medication in many countries; not FDA-approved.
Approval Status
Phase3
Sports Legal
Permitted
References
No references listed.
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.